Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Pfizer
PFE
|
$230M |
| 2 |
Johnson & Johnson
JNJ
|
$204M |
| 3 |
Bank of America
BAC
|
$171M |
| 4 |
Costco
COST
|
$161M |
| 5 |
GSK
GSK
|
$135M |
Top Sells
| 1 |
IBM
IBM
|
$412M |
| 2 |
Bristol-Myers Squibb
BMY
|
$228M |
| 3 |
GE Aerospace
GE
|
$156M |
| 4 |
Walt Disney
DIS
|
$154M |
| 5 |
Amazon
AMZN
|
$138M |
Sector Composition
| 1 | Technology | 14.33% |
| 2 | Healthcare | 13.06% |
| 3 | Consumer Discretionary | 12.03% |
| 4 | Consumer Staples | 11.16% |
| 5 | Industrials | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
McDonald's
MCD
$224B
| $735M | 1.76% | 7,570,700 +108,300 | +1% | +$10.5M |
|
2
Novo Nordisk
NVO
$251B
| $603M | 1.44% | 3,263,700 +127,500 | +4% | +$23.6M |
|
3
TSMC
TSM
$1.2T
| $507M | 1.21% | 29,058,671 +6,256,320 | +27% | +$109M |
|
|
4
Johnson & Johnson
JNJ
$427B
| $504M | 1.21% | 5,498,400 +2,223,100 | +68% | +$204M |
|
|
LLTC
5
DELISTED
Linear Technology Corp
LLTC
| $495M | 1.19% | 10,877,500 +165,200 | +2% | +$7.52M |
|
6
Colgate-Palmolive
CL
$67.9B
| $479M | 1.15% | 7,348,400 -317,100 | -4% | -$20.7M |
|
7
Hershey
HSY
$37.3B
| $421M | 1.01% | 4,334,000 -304,600 | -7% | -$29.6M |
|
8
Eli Lilly
LLY
$657B
| $360M | 0.86% | 7,061,700 -1,226,105 | -15% | -$62.5M |
|
|
9
GSK
GSK
$79.9B
| $343M | 0.82% | 6,425,000 +2,533,700 | +65% | +$135M |
|
|
10
Costco
COST
$418B
| $340M | 0.81% | 2,857,513 +1,355,800 | +90% | +$161M |
|
11
Alaska Air
ALK
$7.24B
| $338M | 0.81% | 4,600,800 +331,700 | +8% | +$24.3M |
|
12
Intel
INTC
$107B
| $295M | 0.71% | 11,370,700 -926,294 | -8% | -$24M |
|
|
WFM
13
DELISTED
Whole Foods Market Inc
WFM
| $287M | 0.69% | 4,954,600 -569,648 | -10% | -$32.9M |
|
14
Verizon
VZ
$186B
| $285M | 0.68% | 5,802,317 +593,000 | +11% | +$29.1M |
|
15
VeriSign
VRSN
$25.5B
| $277M | 0.66% | 4,625,776 -446,800 | -9% | -$26.7M |
|
16
Walmart
WMT
$774B
| $267M | 0.64% | 3,397,000 -392,100 | -10% | -$30.9M |
|
17
TJX Companies
TJX
$152B
| $265M | 0.63% | 4,151,900 -861,900 | -17% | -$54.9M |
|
18
Philip Morris
PM
$260B
| $259M | 0.62% | 2,977,700 -587,800 | -16% | -$51.2M |
|
|
TWTC
19
DELISTED
TW TELECOM INC CL A COM
TWTC
| $258M | 0.62% | 8,466,200 +1,138,000 | +16% | +$34.7M |
|
20
NetEase
NTES
$86.2B
| $250M | 0.6% | 3,182,400 -420,300 | -12% | -$33M |
|
21
Home Depot
HD
$405B
| $246M | 0.59% | 2,989,900 -201,300 | -6% | -$16.6M |
|
|
LIFE
22
DELISTED
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
| $246M | 0.59% | 3,241,897 +1,384,000 | +74% | +$105M |
|
|
CELG
23
DELISTED
Celgene Corp
CELG
| $237M | 0.57% | 1,405,469 -262,131 | -16% | -$44.3M |
|
|
24
Pfizer
PFE
$141B
| $230M | 0.55% | +7,499,841 | New | +$230M |
|
25
Qualcomm
QCOM
$173B
| $217M | 0.52% | 2,916,560 -291,200 | -9% | -$21.6M |
|